Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Christy McLaughlin

Nurse Practitioner, Psychiatric/Mental Health Lafayette, IN Nurse Practitioner

NPI 1578595120 CMS profile 10867701

709 S 18Th St Ste C, Lafayette, IN 47905

Open in the dashboard

General payments

$8,781

505 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christy McLaughlin of Lafayette, IN is reported in the CMS Open Payments database as having received $8,781 across 505 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Nurse Practitioner, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,603 133
2024 General $1,980 104
2023 General $2,169 145
2022 General $1,314 78
2021 General $716 45

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christy McLaughlin
  • Nurse Practitioner, Psychiatric/Mental Health median
  • Middle half of Nurse Practitioner, Psychiatric/Mental Health
  • National median

In program year 2025, general payments to Christy McLaughlin were reported at $2,603. Among 26,152 Nurse Practitioner, Psychiatric/Mental Health profiles paid that year, the median was $258 and the middle half received between $93 and $764.

Show as a table
Year Christy McLaughlin Nurse Practitioner, Psychiatric/Mental Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $716 $166 $54–$482 $132
2022 $1,314 $195 $66–$559 $149
2023 $2,169 $233 $82–$673 $160
2024 $1,980 $236 $84–$688 $164
2025 $2,603 $258 $93–$764 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,412 89 payments
  2. Otsuka America Pharmaceutical, Inc. $782 39 payments
  3. Vanda Pharmaceuticals Inc. $631 25 payments
  4. Axsome Therapeutics, Inc. $576 25 payments
  5. Teva Pharmaceuticals USA, Inc. $570 31 payments
  6. Supernus Pharmaceuticals, Inc. $547 39 payments
  7. Corium, Inc. $514 32 payments
  8. Lundbeck LLC $507 40 payments
  9. Alkermes, Inc. $439 23 payments
  10. Janssen Pharmaceuticals, Inc $397 25 payments
  11. Other $2,406 137 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,729 503 payments
  2. Education $52 2 payments
Products named General payments · program years 2021–2025
  1. VRAYLAR $1,086 66 payments
  2. REXULTI Psychiatry $733 36 payments
  3. FANAPT $631 25 payments
  4. HETLIOZ $598 24 payments
  5. Auvelity $560 23 payments
  6. Azstarys $514 32 payments
  7. LYBALVI $415 22 payments
  8. SPRAVATO $384 24 payments
  9. REXULTI Psychiatry $369 32 payments
  10. Qelbree $368 17 payments
  11. Other $5,601 329 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

505 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Psychiatric/Mental Health in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record